Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there - 2Fuel Price Spike Drives Surge in Used EV Sales in Europe
- 3NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
- 4Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- 5Travels to Dream Objections in Europe
- The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- In the stomach of a mummified wolf pup, scientists find DNA from a woolly rhinoceros
- 6 Famous Urban communities for Shopping on the planet
- Former GLP-1 users regain lost weight after about 18 months, study says
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- New India programme supports tribal families hosting tourists
- Instructions to Shield Your Gold Speculation from Possible Dangers: Fundamental Protections
- Record-breaking flu hospitalizations in New York in a single week: Health officials
